MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ)

Clinical trials for MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ) explained in plain language.

Never miss a new study

Get alerted when new MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ) trials appear

Sign up with your email to follow new studies for MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a simple drug combo heal jaw bone damage?

Disease control Recruiting now

This phase 2 trial tests whether a combination of pentoxifylline and vitamin E can help heal jaw bone damage caused by certain osteoporosis or cancer drugs. The study will enroll 17 adults with stage 2 medication-related osteonecrosis of the jaw. Researchers will measure how many…

Matched conditions: MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ)

Phase: PHASE2 • Sponsor: University Hospital, Limoges • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ)

Get alerted when new MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ) trials appear

Could a simple drug combo heal jaw bone damage?